We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acceptability and Feasibility of Human Papilloma Virus Vaccine

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2010 by Tata Memorial Hospital.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01209338
First Posted: September 27, 2010
Last Update Posted: September 28, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Tata Memorial Hospital
June 16, 2010
September 27, 2010
September 28, 2010
November 2009
December 2010   (Final data collection date for primary outcome measure)
To determine the Knowledge, Attitude and Practice about cervix cancer, Human Papilloma Virus (HPV). [ Time Frame: 8 months ]
  1. To determine the Knowledge, Attitude and Practice about cervix cancer, Human Papilloma Virus (HPV) and HPV Vaccines amongst the target population.
  2. To promote awareness regarding cervix cancer and its screening amongst the community.
  3. To assess the feasibility and logistics of various strategies for reaching girls with HPV Vaccines.
Same as current
Complete list of historical versions of study NCT01209338 on ClinicalTrials.gov Archive Site
. To identify the barriers and facilitators perceived by women for vaccinating their daughters against HPV infection and cervix cancer. [ Time Frame: 8 months ]
To determine barriers and facilitators for vaccine acceptability between sensitized and non- sensitized group.
Same as current
Not Provided
Not Provided
 
Acceptability and Feasibility of Human Papilloma Virus Vaccine
Acceptability and Feasibility of Human Papilloma Virus Vaccine
The overall program goal is to determine the Acceptability and Feasibility of introducing a population based Human Papilloma Virus (HPV) Vaccination programme and understanding the key individual and community factors that would determine the potential acceptability of the vaccine.

The eligible participant will be chosen by door-door household visit. Each participant will be given information regarding the study and written informed consent will be obtained from them. Their participation will be entirely voluntary and no pressure or coercion will be used. Our team will help them with questions that are not well understood by them or are ambiguous for them. The questionnaire is in 2 sections. Section one will try and ascertain the mother's Knowledge, Attitude and Perception regarding cervix cancer, HPV infection and HPV Vaccination.

Section 1 will be interviewed for a period of 5-10 minutes followed by an information sheet providing details on HPV infection, its association with cervix cancer and HPV Vaccination against cervix cancer. The information sheet available will be explained to them for a period of 10-15 minutes. Our social workers will be available at all times to allay their misinterpretations. This will be followed by section 2 which will be a post intervention questionnaire comprising of questions regarding their attitude towards HPV vaccination and identifying barriers and motivators for these women towards vaccination.

The post-intervention questionnaire would be interviewed for a period of 10-15 minutes, thus a total of 25-40 minutes will be made available to every participant for the entire session. The team is expected to cover 15 women per day totaling to 300 women per month considering the monthly holidays and time lost in certain administrative issues.

Patients will be recruited for 4 months which will be followed by data entry, data analysis, formulation of results and write -up. Thus the entire study will last for eight months. The questionnaire consists of mostly close ended questions with options in the form of yes/no/do not know. Some questions which require definitive answers have been provided with plausible options. Some questions have been left open ended so as to avoid ambiguity. The questionnaire is simple, in continuity and is translated into Hindi and Marathi languages so as to meet the needs of the local population.

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Cervical Cancer
Behavioral: Health education
Health education about HPV infection, HPV vaccine and cervix cancer.
  • Active Comparator: sensitized group
    One arm will be a sensitized group which would have received cancer health awareness sessions and / or screening earlier at least once in the past.
    Intervention: Behavioral: Health education
  • No Intervention: non-sensitized group
    The second arm will belong to an area which has never been exposed to any form of cancer awareness or screening activities thus this group is a completely non-sensitized group.
    Intervention: Behavioral: Health education
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
1000
December 2010
December 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

All married women bearing daughters of the age group 10-18 years and are conversant in either Marathi, Hindi or English will be included in the study.

Exclusion Criteria:

Women with no children or with daughters outside the 10-18 yrs age group have been excluded.

Sexes Eligible for Study: Female
18 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
India
 
 
NCT01209338
655
No
Not Provided
Not Provided
Tata Memorial Hospital
Tata Memorial Hospital
Not Provided
Principal Investigator: Sharmila A Pimple, MD Tata Memorial Hospital
Principal Investigator: Gauravi A Mishra, MD Tata Memorial Hospital
Tata Memorial Hospital
September 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP